NOVT Logo

Novanta Inc (NOVT) Stock Forecast & Price Prediction

Live NOVT Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NASDAQ | Technology | Scientific & Technical Instruments

$148.84

+0.97 (0.66%)

12 Month Price Forecast For NOVT

$148.84
Current Price
$5.35B
Market Cap
4 Ratings
Buy 2
Hold 2
Sell 0
Wall St Analyst Ratings

Distance to NOVT Price Forecasts

+25.6%
To High Target of $187.00
+13.5%
To Median Target of $169.00
-7.1%
To Low Target of $138.34

NOVT Price Momentum

-0.2%
1 Week Change
-1.3%
1 Month Change
-5.9%
1 Year Change
-2.6%
Year-to-Date Change
-20.5%
From 52W High of $187.12
+4.0%
From 52W Low of $143.18

๐Ÿค” Considering Novanta (NOVT)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 6, 2025 7:20 PM UTC

NOVT Analyst Ratings & Price Targets

Based on our analysis of 3 Wall Street analysts, NOVT has a consensus that is neutral. The median price target is $169.00, with forecasts ranging from $138.34 to $187.00. Currently, there are 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings.

With NOVT currently trading at $148.84, the median price forecast suggests a 13.5% upside. The most optimistic forecast comes from at , projecting a 25.6% upside, while at provides the most conservative target, suggesting a -7.1% downside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

NOVT Analyst Consensus

2
Buy
2
Hold
0
Sell

NOVT Price Target Range

Low
$138.34
Average
$169.00
High
$187.00
Current: $148.84

Latest NOVT Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for NOVT.

Date Firm Analyst Rating Change Price Target
Nov 6, 2024 Baird Robert Mason Neutral Maintains $169.00
Aug 7, 2024 Baird Robert Mason Neutral Maintains $175.00
May 11, 2023 Baird Robert Mason Neutral Maintains $161.00
May 11, 2022 William Blair Brian Drab Outperform Upgrade $0.00
Nov 13, 2020 Berenberg Hold Initiates $0.00
May 13, 2020 Baird Neutral Maintains $90.00
Feb 28, 2019 Baird Neutral Maintains $81.00
May 9, 2018 Baird Neutral Downgrade $0.00
Feb 27, 2018 William Blair Outperform Initiates $0.00
Dec 8, 2017 Baird Outperform Initiates $0.00

Stocks Similar to Novanta Inc

The following stocks are similar to Novanta based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Novanta Inc (NOVT) Financial Data

Novanta Inc has a market capitalization of $5.35B with a P/E ratio of 89.1x. The company generates $922.75M in trailing twelve-month revenue with a 6.5% profit margin.

Revenue growth is +10.3% quarter-over-quarter, while maintaining an operating margin of +14.3% and return on equity of +8.7%.

Valuation Metrics

Market Cap $5.35B
Enterprise Value $5.77B
P/E Ratio 89.1x
PEG Ratio 39.3x
Price/Sales 5.8x

Growth & Margins

Revenue Growth (YoY) +10.3%
Gross Margin +44.7%
Operating Margin +14.3%
Net Margin +6.5%
EPS Growth -9.6%

Financial Health

Cash/Price Ratio +1.7%
Current Ratio 2.8x
Debt/Equity 69.3x
ROE +8.7%
ROA +5.3%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Novanta Inc logo

Novanta Inc (NOVT) Company Overview

About Novanta Inc

What They Do

Provides precision medicine and automation solutions.

Business Model

Novanta Inc. operates through three main segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The company generates revenue by selling a diverse range of high-tech products including lasers, medical devices, and automation technologies through both direct sales and distributors under various recognized brands.

Additional Information

Founded in 1968 and headquartered in Bedford, Massachusetts, Novanta Inc. has a strong international presence and focuses on innovative solutions in the medical and industrial sectors. The company was formerly known as GSI Group, Inc. and rebranded in May 2016.

Company Information

Sector

Technology

Industry

Scientific & Technical Instruments

Employees

2,900

CEO

Mr. Matthijs Glastra

Country

United States

IPO Year

1999

Novanta Inc (NOVT) Latest News & Analysis

NOVT stock latest news image
Quick Summary

Novanta Inc. (Nasdaq: NOVT) will release its Q4 and full year 2024 results on February 25, 2025, and host a conference call at 10:00 a.m. ET. Access details provided.

Why It Matters

Novanta Inc.'s upcoming earnings release and conference call may impact stock prices, providing insights into financial performance and future growth potential, critical for investment decisions.

Source: Business Wire
Market Sentiment: Neutral
NOVT stock latest news image
Quick Summary

Novanta Inc. will participate in the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on January 14, 2025, held virtually.

Why It Matters

Novanta Inc.'s participation in a prominent investor conference signals potential growth opportunities and investor interest, impacting stock performance and market perception.

Source: Business Wire
Market Sentiment: Neutral
NOVT stock latest news image
Quick Summary

Novanta Inc. (Nasdaq: NOVT) will present at the J.P. Morgan Healthcare Conference on January 13, 2025, in San Francisco, featuring CEO Matthijs Glastra and CFO Robert Buckley.

Why It Matters

Novanta's presentation at a major healthcare conference may signal strategic developments, influencing investor confidence and potential stock movement in the medical technology sector.

Source: Business Wire
Market Sentiment: Neutral
NOVT stock latest news image
Quick Summary

Novanta Inc. will hold its Q3 2024 results conference call on November 5, 2024, at 10:00 AM ET, featuring executives including CEO Matthijs Glastra and CFO Robert Buckley.

Why It Matters

Novanta Inc.'s Q3 2024 results call could reveal insights into financial performance and future guidance, influencing stock valuation and investor sentiment.

Source: Seeking Alpha
Market Sentiment: Neutral
NOVT stock latest news image
Quick Summary

Novanta Inc. reported Q3 2024 revenue of $244.4M, up from $221.5M in Q3 2023. Operating income increased to $32.6M, while net income decreased to $19.2M, with diluted EPS not specified.

Why It Matters

Novanta's Q3 2024 revenue growth indicates strong demand, but a dip in net income and EPS suggests potential profitability concerns, impacting investor sentiment and valuation.

Source: Business Wire
Market Sentiment: Neutral
NOVT stock latest news image
Quick Summary

Novanta (NOVT) reported Q3 earnings of $0.85 per share, missing the consensus estimate of $0.86. Earnings remained unchanged from $0.85 per share in the same quarter last year.

Why It Matters

Novanta's earnings miss may signal weaker operational performance, potentially affecting investor confidence and stock valuation. Consistent earnings could impact future growth expectations.

Source: Zacks Investment Research
Market Sentiment: Negative

Frequently Asked Questions About NOVT Stock

What is Novanta Inc's (NOVT) stock forecast for 2025?

Based on our analysis of 3 Wall Street analysts, Novanta Inc (NOVT) has a median price target of $169.00. The highest price target is $187.00 and the lowest is $138.34.

Is NOVT stock a good investment in 2025?

According to current analyst ratings, NOVT has 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $148.84. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for NOVT stock?

Wall Street analysts predict NOVT stock could reach $169.00 in the next 12 months. This represents a 13.5% increase from the current price of $148.84. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Novanta Inc's business model?

Novanta Inc. operates through three main segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The company generates revenue by selling a diverse range of high-tech products including lasers, medical devices, and automation technologies through both direct sales and distributors under various recognized brands.

What is the highest forecasted price for NOVT Novanta Inc?

The highest price target for NOVT is $187.00 from at , which represents a 25.6% increase from the current price of $148.84.

What is the lowest forecasted price for NOVT Novanta Inc?

The lowest price target for NOVT is $138.34 from at , which represents a -7.1% decrease from the current price of $148.84.

What is the overall NOVT consensus from analysts for Novanta Inc?

The overall analyst consensus for NOVT is neutral. Out of 3 Wall Street analysts, 2 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $169.00.

How accurate are NOVT stock price projections?

Stock price projections, including those for Novanta Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.